• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RMD
Click for more information
0.54% $37.28

RESMED INC - Announcements

Market Cap $22.38B  ! watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
Filters [Clear]
  • Price Sensitive: Yes
RMD RMD & FPH Announce Settlement of Global Patent LitigationPRICE SENSITIVE21/02/19
RMD ResMed Announces Results for the Second Quarter of FY 2019PRICE SENSITIVE25/01/19
RMD FORM 8-KPRICE SENSITIVE09/11/18
RMD FORM 8-KPRICE SENSITIVE06/11/18
RMD ResMed Announces Results for the First Quarter of FY 2019PRICE SENSITIVE26/10/18
RMD FORM 8-KPRICE SENSITIVE26/10/18
RMD Dividend/Distribution - RMDPRICE SENSITIVE03/08/18
RMD Financial Results for the Fourth Quarter & Fiscal Year 2018PRICE SENSITIVE03/08/18
RMD ResMed FORM SDPRICE SENSITIVE30/05/18 download Created with Sketch. 69.8KB
RMD ResMed Announces Results for the Third Quarter of FY 2018PRICE SENSITIVE27/04/18
RMD Form 8KPRICE SENSITIVE20/04/18
RMD ResMed Announces Results for the Second Qtr of FY 2018PRICE SENSITIVE23/01/18
RMD FPH:FPH Files Patent Infringement Proceeding Against ResMedPRICE SENSITIVE12/12/17
RMD Form 10Q for QTR ended September 30, 2017PRICE SENSITIVE30/10/17
RMD ResMed Announces Results for the First Quarter of FY 2018PRICE SENSITIVE27/10/17
RMD Financial Results for the Fourth Quarter & Fiscal Year 2017PRICE SENSITIVE02/08/17
RMD Conflict Minerals ReportPRICE SENSITIVE25/05/17
RMD ResMed Plans to Renew Patent Case against Fisher & PaykelPRICE SENSITIVE18/05/17
RMD FPH: Withdrawal of US ITC Complaint Against FPHPRICE SENSITIVE17/05/17
RMD ResMed Announces Results for the Third Quarter of FY 2017PRICE SENSITIVE28/04/17
RMD ResMed Announces Results for the Second Qtr of FY 2017PRICE SENSITIVE25/01/17
RMD ResMed Announces Results for the Second Qtr of FY 2017PRICE SENSITIVE24/01/17
RMD Form 8-KPRICE SENSITIVE13/01/17
RMD FPH Contests Patent Infringement Allegations,RMD-FPH.NZ PRICE SENSITIVE18/08/16
RMD FPH FILE PATENT INFRINGEMENT PROCEEDINGS AGAINST RESMED,RMD-FPH.NZ PRICE SENSITIVE16/08/16
RMD Financial Results for the Fourth Quarter & Fiscal Year 2016-RMD.N PRICE SENSITIVE29/07/16
RMD ResMed Announces Results for the Third Qtr of FY 2016-RMD.N PRICE SENSITIVE27/04/16
RMD Termination of relationshipPRICE SENSITIVE24/03/16
RMD ResMed to Acquire BrightreePRICE SENSITIVE23/02/16
RMD ResMed Announces Results for the Second Qtr of FY 2016PRICE SENSITIVE22/01/16
RMD ResMed Announces Results for the First Qtr of FY 2016PRICE SENSITIVE23/10/15
RMD Financial Results for the Fourth Quarter & Fiscal Year 2015PRICE SENSITIVE31/07/15
RMD ResMed FORM SDPRICE SENSITIVE28/05/15
RMD ResMed Inc to sell Mute snoring & sleep technologyPRICE SENSITIVE15/05/15
RMD Form 8-KPRICE SENSITIVE14/05/15
RMD Financial Results for Quarter Ended March 31, 2015PRICE SENSITIVE24/04/15
RMD Form 10Q for QTR ended December 31, 2014PRICE SENSITIVE02/02/15
RMD RESMED TO ANNOUNCE SECOND QUARTER 2015 RESULTSPRICE SENSITIVE23/01/15
RMD Financial Results for Quarter Ended September 30, 2014PRICE SENSITIVE24/10/14
RMD Financial Results For 4th Qtr 14 & Fiscal Year 2014PRICE SENSITIVE01/08/14
RMDRecord Financial Results for Quarter Ended March 31,2014PRICE SENSITIVE24/04/14
RMDForm 8 - KPRICE SENSITIVE28/02/14
RMDRecord Financial Results for Quarter Ended December 31,2013PRICE SENSITIVE24/01/14
RMDNew Credit Facility - Form 8-KPRICE SENSITIVE06/11/13
RMDRecord Financial Results for Quarter Ended September 30,2013PRICE SENSITIVE25/10/13
RMDRecord Financial Results For 4Q13 & Fiscal Year-EndPRICE SENSITIVE02/08/13
RMDResMed Succeeds in Patent Fight Against APEXPRICE SENSITIVE19/07/13
RMDResMed and University of Sydney Partnership AgreementPRICE SENSITIVE14/05/13
RMDRecord Financial Results for Q/E & 9 Months Mar 31, 2013PRICE SENSITIVE26/04/13
RMDResMed Appoints CEO & COOPRICE SENSITIVE27/02/13
RMDRESMED APPOINTS MICHAEL FARRELL AS CHIEF EXECUTIVE OFFICERPRICE SENSITIVE21/02/13
RMDRecord Financial Results for Q/E & 6 Months Dec 31, 2012PRICE SENSITIVE25/01/13
RMDForm 10Q for QTR ended September 30, 2012PRICE SENSITIVE01/11/12
RMDRecord Financial Results for Quarter Ended September 30,2012PRICE SENSITIVE26/10/12
RMDRecord Financial Results for 4Q12 & Fiscal Year-EndPRICE SENSITIVE03/08/12
RMDRESMED INITIATES DIVIDEND PLAN AND CEO UPDATEPRICE SENSITIVE18/05/12
RMDRecord Financial Results for Quarter Ended March 31, 2012PRICE SENSITIVE27/04/12
RMDAmendment to Credit AgreementPRICE SENSITIVE27/01/12
RMDRecord Financial Results for the Q/E December 31, 2011PRICE SENSITIVE27/01/12
RMDFinancial Results For The Quarter Ended Sep 30, 2011PRICE SENSITIVE25/10/11
RMDAppendix 4E and Form 10 kPRICE SENSITIVE18/08/11
RMDRecord Results for the Quarter and 12 months June 30, 2011PRICE SENSITIVE05/08/11
RMDResmed and CareFusion Announce Distribution AgreementPRICE SENSITIVE26/07/11
RMDRESMED ANNOUNCES ACQUISITION OF BIANCAMEDPRICE SENSITIVE07/07/11
RMDRecord Financial Results for Qtr and 9 months March 31, 2011PRICE SENSITIVE29/04/11
RMDRMD announces the release of it's new S9VPAP seriesPRICE SENSITIVE12/04/11
RMDCredit AgreementPRICE SENSITIVE15/02/11
RMDHalf Year report and Form 10Q for December 31, 2010PRICE SENSITIVE04/02/11
RMDAnnounces Management ChangesPRICE SENSITIVE02/02/11
RMDFinancial results for the Quarter ended December 31, 2010PRICE SENSITIVE28/01/11
RMDFinancial results for the Quarter ended September 30, 2010PRICE SENSITIVE29/10/10
RMDRESMED'S NEW CPAP DEVICE INCREASES PATIENT COMPLIANCEPRICE SENSITIVE17/09/10
RMDAppendix 4E and Form 10-KPRICE SENSITIVE18/08/10
RMDFinancial results for 4th Qtr and Year ended 30 June 2010PRICE SENSITIVE06/08/10
RMDFinancial results for the Quarter ended March 31, 2010PRICE SENSITIVE30/04/10
RMDHalf Year ReportPRICE SENSITIVE18/02/10
RMDForm 10Q for Qtr ended December 31, 2009PRICE SENSITIVE08/02/10
RMDRecord Financial results - Qtr and Six months ended 31/12/09PRICE SENSITIVE05/02/10
RMDFinancial results for the Quarter ended September 30, 2009PRICE SENSITIVE06/11/09
RMDAppendix 4E and Form 10KPRICE SENSITIVE24/08/09
RMDRecord Financial Results For The Qtr and Y/E June 30, 2009PRICE SENSITIVE07/08/09
RMDRecord results for the quarter ended March 31, 2009PRICE SENSITIVE08/05/09
RMDHalf Yearly Report and AccountsPRICE SENSITIVE09/02/09
RMDRecord Financial Results For The Qtr Ended Dec 31, 2008PRICE SENSITIVE06/02/09
RMD RMD & FPH Announce Settlement of Global Patent Litigation
21/02/19PRICE SENSITIVE
RMD ResMed Announces Results for the Second Quarter of FY 2019
25/01/19PRICE SENSITIVE
RMD FORM 8-K
09/11/18PRICE SENSITIVE
RMD FORM 8-K
06/11/18PRICE SENSITIVE
RMD ResMed Announces Results for the First Quarter of FY 2019
26/10/18PRICE SENSITIVE
RMD FORM 8-K
26/10/18PRICE SENSITIVE
RMD Dividend/Distribution - RMD
03/08/18PRICE SENSITIVE
RMD Financial Results for the Fourth Quarter & Fiscal Year 2018
03/08/18PRICE SENSITIVE
RMD ResMed FORM SD
30/05/18PRICE SENSITIVE download Created with Sketch. 69.8KB
RMD ResMed Announces Results for the Third Quarter of FY 2018
27/04/18PRICE SENSITIVE
RMD Form 8K
20/04/18PRICE SENSITIVE
RMD ResMed Announces Results for the Second Qtr of FY 2018
23/01/18PRICE SENSITIVE
RMD FPH:FPH Files Patent Infringement Proceeding Against ResMed
12/12/17PRICE SENSITIVE
RMD Form 10Q for QTR ended September 30, 2017
30/10/17PRICE SENSITIVE
RMD ResMed Announces Results for the First Quarter of FY 2018
27/10/17PRICE SENSITIVE
RMD Financial Results for the Fourth Quarter & Fiscal Year 2017
02/08/17PRICE SENSITIVE
RMD Conflict Minerals Report
25/05/17PRICE SENSITIVE
RMD ResMed Plans to Renew Patent Case against Fisher & Paykel
18/05/17PRICE SENSITIVE
RMD FPH: Withdrawal of US ITC Complaint Against FPH
17/05/17PRICE SENSITIVE
RMD ResMed Announces Results for the Third Quarter of FY 2017
28/04/17PRICE SENSITIVE
RMD ResMed Announces Results for the Second Qtr of FY 2017
25/01/17PRICE SENSITIVE
RMD ResMed Announces Results for the Second Qtr of FY 2017
24/01/17PRICE SENSITIVE
RMD Form 8-K
13/01/17PRICE SENSITIVE
RMD FPH Contests Patent Infringement Allegations,RMD-FPH.NZ
18/08/16PRICE SENSITIVE
RMD FPH FILE PATENT INFRINGEMENT PROCEEDINGS AGAINST RESMED,RMD-FPH.NZ
16/08/16PRICE SENSITIVE
RMD Financial Results for the Fourth Quarter & Fiscal Year 2016-RMD.N
29/07/16PRICE SENSITIVE
RMD ResMed Announces Results for the Third Qtr of FY 2016-RMD.N
27/04/16PRICE SENSITIVE
RMD Termination of relationship
24/03/16PRICE SENSITIVE
RMD ResMed to Acquire Brightree
23/02/16PRICE SENSITIVE
RMD ResMed Announces Results for the Second Qtr of FY 2016
22/01/16PRICE SENSITIVE
RMD ResMed Announces Results for the First Qtr of FY 2016
23/10/15PRICE SENSITIVE
RMD Financial Results for the Fourth Quarter & Fiscal Year 2015
31/07/15PRICE SENSITIVE
RMD ResMed FORM SD
28/05/15PRICE SENSITIVE
RMD ResMed Inc to sell Mute snoring & sleep technology
15/05/15PRICE SENSITIVE
RMD Form 8-K
14/05/15PRICE SENSITIVE
RMD Financial Results for Quarter Ended March 31, 2015
24/04/15PRICE SENSITIVE
RMD Form 10Q for QTR ended December 31, 2014
02/02/15PRICE SENSITIVE
RMD RESMED TO ANNOUNCE SECOND QUARTER 2015 RESULTS
23/01/15PRICE SENSITIVE
RMD Financial Results for Quarter Ended September 30, 2014
24/10/14PRICE SENSITIVE
RMD Financial Results For 4th Qtr 14 & Fiscal Year 2014
01/08/14PRICE SENSITIVE
RMDRecord Financial Results for Quarter Ended March 31,2014
24/04/14PRICE SENSITIVE
RMDForm 8 - K
28/02/14PRICE SENSITIVE
RMDRecord Financial Results for Quarter Ended December 31,2013
24/01/14PRICE SENSITIVE
RMDNew Credit Facility - Form 8-K
06/11/13PRICE SENSITIVE
RMDRecord Financial Results for Quarter Ended September 30,2013
25/10/13PRICE SENSITIVE
RMDRecord Financial Results For 4Q13 & Fiscal Year-End
02/08/13PRICE SENSITIVE
RMDResMed Succeeds in Patent Fight Against APEX
19/07/13PRICE SENSITIVE
RMDResMed and University of Sydney Partnership Agreement
14/05/13PRICE SENSITIVE
RMDRecord Financial Results for Q/E & 9 Months Mar 31, 2013
26/04/13PRICE SENSITIVE
RMDResMed Appoints CEO & COO
27/02/13PRICE SENSITIVE
RMDRESMED APPOINTS MICHAEL FARRELL AS CHIEF EXECUTIVE OFFICER
21/02/13PRICE SENSITIVE
RMDRecord Financial Results for Q/E & 6 Months Dec 31, 2012
25/01/13PRICE SENSITIVE
RMDForm 10Q for QTR ended September 30, 2012
01/11/12PRICE SENSITIVE
RMDRecord Financial Results for Quarter Ended September 30,2012
26/10/12PRICE SENSITIVE
RMDRecord Financial Results for 4Q12 & Fiscal Year-End
03/08/12PRICE SENSITIVE
RMDRESMED INITIATES DIVIDEND PLAN AND CEO UPDATE
18/05/12PRICE SENSITIVE
RMDRecord Financial Results for Quarter Ended March 31, 2012
27/04/12PRICE SENSITIVE
RMDAmendment to Credit Agreement
27/01/12PRICE SENSITIVE
RMDRecord Financial Results for the Q/E December 31, 2011
27/01/12PRICE SENSITIVE
RMDFinancial Results For The Quarter Ended Sep 30, 2011
25/10/11PRICE SENSITIVE
RMDAppendix 4E and Form 10 k
18/08/11PRICE SENSITIVE
RMDRecord Results for the Quarter and 12 months June 30, 2011
05/08/11PRICE SENSITIVE
RMDResmed and CareFusion Announce Distribution Agreement
26/07/11PRICE SENSITIVE
RMDRESMED ANNOUNCES ACQUISITION OF BIANCAMED
07/07/11PRICE SENSITIVE
RMDRecord Financial Results for Qtr and 9 months March 31, 2011
29/04/11PRICE SENSITIVE
RMDRMD announces the release of it's new S9VPAP series
12/04/11PRICE SENSITIVE
RMDCredit Agreement
15/02/11PRICE SENSITIVE
RMDHalf Year report and Form 10Q for December 31, 2010
04/02/11PRICE SENSITIVE
RMDAnnounces Management Changes
02/02/11PRICE SENSITIVE
RMDFinancial results for the Quarter ended December 31, 2010
28/01/11PRICE SENSITIVE
RMDFinancial results for the Quarter ended September 30, 2010
29/10/10PRICE SENSITIVE
RMDRESMED'S NEW CPAP DEVICE INCREASES PATIENT COMPLIANCE
17/09/10PRICE SENSITIVE
RMDAppendix 4E and Form 10-K
18/08/10PRICE SENSITIVE
RMDFinancial results for 4th Qtr and Year ended 30 June 2010
06/08/10PRICE SENSITIVE
RMDFinancial results for the Quarter ended March 31, 2010
30/04/10PRICE SENSITIVE
RMDHalf Year Report
18/02/10PRICE SENSITIVE
RMDForm 10Q for Qtr ended December 31, 2009
08/02/10PRICE SENSITIVE
RMDRecord Financial results - Qtr and Six months ended 31/12/09
05/02/10PRICE SENSITIVE
RMDFinancial results for the Quarter ended September 30, 2009
06/11/09PRICE SENSITIVE
RMDAppendix 4E and Form 10K
24/08/09PRICE SENSITIVE
RMDRecord Financial Results For The Qtr and Y/E June 30, 2009
07/08/09PRICE SENSITIVE
RMDRecord results for the quarter ended March 31, 2009
08/05/09PRICE SENSITIVE
RMDHalf Yearly Report and Accounts
09/02/09PRICE SENSITIVE
RMDRecord Financial Results For The Qtr Ended Dec 31, 2008
06/02/09PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
$37.28 		Change
0.200(0.54%) 		Mkt cap ! $22.38B
Open High Low Value Volume
$37.50 $37.55 $37.15 $17.93M 480.5K

Buyers (Bids)

No. Vol. Price($)
1 3363 $37.27
 

Sellers (Offers)

Price($) Vol. No.
$37.30 1001 2
View Market Depth
Last trade - 16.10pm 22/11/2024 (20 minute delay) ?
Last
$37.23 		  Change
0.200 ( 0.58 %)
Open High Low Volume
$37.47 $37.55 $37.16 98352
Last updated 15.59pm 22/11/2024 ?
RMD (ASX) Chart

Top Stories

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
Scientific conference spotlights PYC's work on blindness disease treatment PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
Sales growth pushes Lovisa's fortunes (and shares) upwards Lovisa Holdings Ltd has seen its shares rise more than 2% following a sales update, and on a good day for the consumer discretionary sector
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.